Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
Warm at the injection site; Itchy at the injection site; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of injection site warmth in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced injection site warmth (Verbatim: Warm at the injection site) and injection site itching (Verbatim: Itchy at the injection site). The outcome of the injection site warmth and injection site itching were not reported. It was unknown if the reporter considered the injection site warmth and injection site itching to be related to Shingles vaccine. It was unknown if the company considered the injection site warmth and injection site itching to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 04-APR-2025 This case was reported by a patient via interactive digital media. The patient self reported this case for himself/herself. Patient had received the set of vaccines for shingles and experienced nothing at all. Warmth and itchiness at the injection site were the only indications.